Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Operating Margin: 2011-2025

Historic Operating Margin for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Sep 2025 value amounting to 44.66%.

  • Catalyst Pharmaceuticals' Operating Margin rose 510.00% to 44.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 44.76%, marking a year-over-year increase of 697.00%. This contributed to the annual value of 39.68% for FY2024, which is 1788.00% up from last year.
  • According to the latest figures from Q3 2025, Catalyst Pharmaceuticals' Operating Margin is 44.66%, which was down 1.28% from 45.24% recorded in Q2 2025.
  • Over the past 5 years, Catalyst Pharmaceuticals' Operating Margin peaked at 53.79% during Q2 2022, and registered a low of -36.21% during Q3 2023.
  • For the 3-year period, Catalyst Pharmaceuticals' Operating Margin averaged around 34.58%, with its median value being 44.21% (2024).
  • In the last 5 years, Catalyst Pharmaceuticals' Operating Margin tumbled by 8,007bps in 2023 and then spiked by 7,577bps in 2024.
  • Over the past 5 years, Catalyst Pharmaceuticals' Operating Margin (Quarterly) stood at 33.26% in 2021, then skyrocketed by 1,743bps to 50.70% in 2022, then crashed by 1,299bps to 37.71% in 2023, then surged by 660bps to 44.31% in 2024, then spiked by 510bps to 44.66% in 2025.
  • Its Operating Margin stands at 44.66% for Q3 2025, versus 45.24% for Q2 2025 and 44.81% for Q1 2025.